Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of the engineering evaluation is to verify and validate the design of an eye movement monitor device, the Retitrack, for recording, viewing, measuring, and analyzing temporal characteristics of fixation and saccadic responses in human eyes when viewing a visual stimulus.
This engineering evaluation is not an applicable clinical trial. This is a design validation of the mechanism of action of the device to measure eye movement. This is not a clinical trial to evaluate the effect of an intervention on biomedical or other health-related outcomes.
This non-significant risk device evaluation involves obtaining retinal images and eye movement measurements with the Retitrack device for purposes of design verification and validation testing. These measurements are not intended for use in diagnosing, preventing, monitoring, or alleviating a medical condition. This evaluation is not intended to assess biomedical or other health-related outcomes.
The evaluation involves the voluntary participation of up to 40 healthy adults who participate in a single device testing visit conducted over one or two days. The Retitrack is used to assess the alignment of the eye for image capture, the ability to measure and analyze eye movements for fixational and visually guided saccadic responses, and the usability of the device.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Design validation of mechanism of action of an eye movement measurement device | Experimental | Participants have retinal images captured with the Retitrack device to measure eye movements. The eye movement measurements are intended to validate the mechanism of action of the device. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Retitrack | Device | Retitrack device measures and analyzes eye movement |
|
| Measure | Description | Time Frame |
|---|---|---|
| Device measurement of involuntary fixational microsaccade amplitude | Microsaccade amplitude (in degrees) | 1 day (Single timepoint) |
| Device measurement of involuntary fixational microsaccade velocity | Microsaccade velocity (in degrees/second) | 1 day (Single timepoint) |
| Device measurement of visually guided horizontal saccade amplitude | Horizontal saccade amplitude (in degrees) | 1 day (Single timepoint) |
| Device measurement of visually guided horizontal saccade velocity | Horizontal saccade velocity (in degrees/second) | 1 day (Single timepoint) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jacqueline Theis, OD | Concussion Care Centre of Virginia, Ltd. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Blur Product Development | Cary | North Carolina | 27513 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Subjects participated in a design validation to evaluate the mechanism of action of the device to measure eye movement. This is not an applicable clinical trial to evaluate the effect of an intervention on biomedical or other health-related outcomes.
Not provided
Not provided
Not provided
Not provided